Anticancer effects of brusatol in nasopharyngeal carcinoma through suppression of the Akt/mTOR signaling pathway

ConclusionsThese observations indicate that brusatol is a promising antitumor drug candidate or a supplement to current chemotherapeutic therapies to treat NPC.

Source: Cancer Chemotherapy and Pharmacology - May 23, 2020 Category: Cancer & Oncology Source Type: research